Search Results - CQ Deng
- Showing 1 - 2 results of 2
-
1
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis by Steven D. Nathan, Jürgen Behr, Vincent Cottin, Lisa Lancaster, Peter Smith, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson, Kevin R. Flaherty
Published 2022Artigo -
2
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension by Sitbon, Olivier, Nikkho, Sylvia, Benza, Raymond, (CQ) Deng, Chunqin, Farber, Harrison W., Gomberg-Maitland, Mardi, Hassoun, Paul, Meier, Christian, Pepke-Zaba, Joanna, Prasad, Krishna, Seeger, Werner, Corris, Paul A
Published 2020Text
Search Tools:
Related Subjects
Adverse effect
Clinical endpoint
Clinical trial
Data monitoring committee
Diffusing capacity
Exacerbation
Guideline
Idiopathic pulmonary fibrosis
Intensive care medicine
Internal medicine
Interstitial lung disease
Lung
Lung function
Medicine
Nintedanib
Pathology
Pirfenidone
Pulmonary hypertension
Treprostinil
Vital capacity